Eurofins: EPS up 41% in 2024
(CercleFinance.com) - Eurofins Scientific reports 2024 EPS that is up 41% at E1.
87, with an adjusted EBITDA that rose 13.8% to E1.55bn, in line with the mid-point of its target range provided in October.
Also in line with its latest forecast of 'close to seven billion euros', the bio-analysis services group's sales rose by 6.7% to E6.95bn (+4.7% organic), exceeding its previous Covid-19 record.
After the disruptions caused by the pandemic and the war in Ukraine, 2024 was the first year of relative stability since 2019, where the continuation of historical trends of profitability growth and are clearly visible, it says.
For FY 2025, Eurofins notably anticipates its adjusted EBITDA margin improving on last year's level of 22.3%, as well as organic growth in the mid-single-digit range.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
87, with an adjusted EBITDA that rose 13.8% to E1.55bn, in line with the mid-point of its target range provided in October.
Also in line with its latest forecast of 'close to seven billion euros', the bio-analysis services group's sales rose by 6.7% to E6.95bn (+4.7% organic), exceeding its previous Covid-19 record.
After the disruptions caused by the pandemic and the war in Ukraine, 2024 was the first year of relative stability since 2019, where the continuation of historical trends of profitability growth and are clearly visible, it says.
For FY 2025, Eurofins notably anticipates its adjusted EBITDA margin improving on last year's level of 22.3%, as well as organic growth in the mid-single-digit range.
Copyright (c) 2025 CercleFinance.com. All rights reserved.